id: healthcare_access_barriers_covid19_to_substance_related_consequences
name: Difficulty Accessing Healthcare/Medication During COVID-19 â†’ Substance-Related
  Consequences
from_node:
  node_id: healthcare_access_barriers_covid19
  node_name: Difficulty Accessing Healthcare/Medication During COVID-19
to_node:
  node_id: substance_related_consequences
  node_name: Substance-Related Consequences
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: COVID-19 pandemic disrupts healthcare systems, creating barriers to accessing
  addiction treatment services and medication (buprenorphine)'
- 'Step 2: Reduced access to healthcare and medication interrupts continuity of opioid
  use disorder treatment'
- 'Step 3: Treatment interruptions increase risk of relapse and inadequate symptom
  management'
- 'Step 4: Increased substance use and inadequate treatment support lead to greater
  substance-related consequences (overdose, legal problems, social/occupational dysfunction)'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Zoe M Weinstein et al. "The Impact of COVID-19 on Substance Use
    and Related Consequences Among Patients in Office-based Opioid Use Disorder Treatment.."
    *Journal of addiction medicine*. https://doi.org/10.1097/ADM.0000000000001367
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.739412'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/healthcare_access_barriers_covid19_to_substance_related_consequences.yaml
_category: healthcare_access
